Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-08

FDA Approved: CEVIMELINE — Original Application (Bionpharma Inc)

View source ↗

Summary

FDA approved an original ANDA for cevimeline hydrochloride (CEVIMELINE), a generic oral therapy from Bionpharma Inc, for the treatment of xerostomia in Sjögren'…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CEVIMELINE (cevimeline hydrochloride)

Snippet

ORIG AP for CEVIMELINE (CEVIMELINE HYDROCHLORIDE)